Introduction In the domain of oncology, immunotherapy has emerged as a pioneering methodology, harnessing the body's immune system to combat malignant tumors. There are many immunotherapeutic approaches, but Chimeric Antigen Rece..
Introduction Cytokine Release Syndrome (CRS) is an immune system overreaction triggered by therapies like immunotherapy or CAR-T cell treatment. It prompts an influx of cytokines, causing symptoms ranging from fever to potentiall..
Patients undergoing outpatient CAR T-cell therapy for cancer must be cared for by a multidisciplinary team that includes nurse coordinators, according to a poster presented at the 49th Annual Oncology Nursing Society Conference. ..
Introduction CAR T cell therapy, an innovative form of immunotherapy, has demonstrated exceptional efficacy in the treatment of specific tumors by leveraging the potency of a patient's own immune system. Recently, scientists have..
Feb 2024: China's pioneering efforts in creating breakthrough cancer therapeutics have gained traction with the introduction of chimeric antigen receptor (CAR)-engineered T-cell (CAR T) therapy for multiple myeloma, a devastatin..
Discover the magic of CAR-T treatment! Read our blog on patient selection for CAR T therapy. Are you the ideal candidate for this innovative cancer treatment? Find out and begin your personalized journey to cancer recovery. He..
The revolutionary CAR T Cell Therapy is changing the scenario of how we deal with cancer, making it more personal and powerful. This latest therapy uses a patient's own immune cells and genetically modifies them to target and des..
Mei 2023: Terapi sel T reseptor antigen chimeric (CAR) ialah pembangunan inovatif dalam bidang terapi kanser individu. Sel-T pesakit sendiri diubah suai secara genetik semasa proses pembuatan untuk mengekspresikan a..
Mac 2023: Bab pertama memoir Sam Neill akan menjadi kejutan yang luar biasa kepada seseorang yang tidak mengetahuinya terlebih dahulu. Ia bermula dengan cukup lucu: benang yang hebat tentang anak perempuannya Elena yang disoal tentang jodoh bapanya..
Mac 2023: Ringkasan Ringkas: Tujuan percubaan klinikal ini adalah untuk mengetahui sama ada terapi sel T CAR reseptor antigen anti-MESO boleh digunakan untuk merawat kanser ovari epitelium yang telah kembali atau berhenti bertindak balas terhadap kanser ovari lain.